Unlocking the potential of
genomic medicine

2018 News Releases

Date Title
Toggle Summary08/23/2010
Toggle Summary07/19/2010
  Higher Dose EPO Biopumps Produce Dose-Dependent Increases in Haemoglobin      Misgav, Israel and London, UK -19 July 2010 - Medgenics, Inc. (AIM: MEDG, MEDU), the company that has developed a novel technology for the manufacture and delivery of therapeutic proteins
Toggle Summary06/22/2010
Misgav, Israel and London, UK -22 June 2010 - Medgenics, Inc. (AIM: MEDG, MEDU), the company that has developed a novel technology for the manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, is pleased to announce that the first new patients have now
Toggle Summary06/09/2010
Misgav, Israel and London, UK -9 June 2010 - Medgenics, Inc. (AIM: MEDG, MEDU), the company that has developed a novel technology for the manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, announces  the addition of a highly experienced
Toggle Summary05/26/2010
Toggle Summary05/17/2010
Medgenics (LSE: MEDG, MEDU), the company that is developing a novel approach to the manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, is proud to announce today the appointment of Nomura Code Securities as joint-broker to the Company with SVS
Toggle Summary04/27/2010
Toggle Summary04/15/2010
Toggle Summary03/30/2010
Toggle Summary10/23/2009